In the last trading session, 3.21 million NRX Pharmaceuticals Inc (NASDAQ:NRXP) shares changed hands as the company’s beta touched 0.93. With the company’s per share price at $4.91 changed hands at $0.06 or 1.24% during last session, the market valuation stood at $59.39M. NRXP’s last price was a discount, traded about -49.29% off its 52-week high of $7.33. The share price had its 52-week low at $1.10, which suggests the last value was 77.6% up since then. When we look at NRX Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 4.58 million shares, with the 3-month average coming to 941.48K.
Analysts gave the NRX Pharmaceuticals Inc (NRXP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NRXP as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information
Instantly NRXP was in green as seen at the end of in last trading. With action 82.53%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 123.18%, with the 5-day performance at 82.53% in the green. However, in the 30-day time frame, NRX Pharmaceuticals Inc (NASDAQ:NRXP) is 305.79% up. Looking at the short shares, we see there were 0.68 million shares sold at short interest cover period of 4.8 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need a downside of -145.5% from its current market value. According to analyst projections, NRXP’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a 59.27% surge from its current level, while the stock would need to tank 59.27% for it to hit the projected low.
NRX Pharmaceuticals Inc (NRXP) estimates and forecasts
Data shows that the NRX Pharmaceuticals Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 97.98% over the past 6 months, a 52.70% in annual growth rate that is considerably higher than the industry average of 16.20%.
The 2025 estimates are for NRX Pharmaceuticals Inc earnings to increase by 53.58%.
NRXP Dividends
NRX Pharmaceuticals Inc is expected to release its next quarterly earnings report in February.
NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 23.56% of NRX Pharmaceuticals Inc shares while 6.05% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.92%.
